HC Wainwright Has Bearish Outlook for AnaptysBio Q2 Earnings
AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) – Equities research analysts at HC Wainwright reduced their Q2 2025 earnings per share estimates for shares of AnaptysBio in a research report issued on Tuesday, May 6th. HC Wainwright analyst E. Bodnar now anticipates that the biotechnology company will earn ($1.81) per share for the quarter, down from […]
AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) – Equities research analysts at HC Wainwright reduced their Q2 2025 earnings per share estimates for shares of AnaptysBio in a research report issued on Tuesday, May 6th. HC Wainwright analyst E. Bodnar now anticipates that the biotechnology company will earn ($1.81) per share for the quarter, down from […]
